SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-22-033259
Filing Date
2022-06-16
Accepted
2022-06-16 12:55:39
Documents
2
Group Members
MAXIM PARTNERS LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea161573-13ga1michael_comera.htm SC 13G/A 51448
2 JOINT FILING AGREEMENT ea161573ex99-1_comera.htm EX-1 3701
  Complete submission text file 0001213900-22-033259.txt   56442
Mailing Address MAXIM GROUP, LLC 405 LEXINGTON AVENUE NEW YORK NY 10174
Business Address
Rabinowitz Michael (Filed by) CIK: 0001767090 (see all company filings)

Type: SC 13G/A

Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 617.871.2101 EXT 313
Comera Life Sciences Holdings, Inc. (Subject) CIK: 0001907685 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93682 | Film No.: 221019951
SIC: 2834 Pharmaceutical Preparations